These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25027934)

  • 1. Synthesis of lantadene analogs with marked in vitro inhibition of lung adenocarcinoma and TNF-α induced nuclear factor-kappa B (NF-κB) activation.
    Monika ; Sharma A; Suthar SK; Aggarwal V; Lee HB; Sharma M
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3814-8. PubMed ID: 25027934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel lung adenocarcinoma and nuclear factor-kappa B (NF-κB) inhibitors: synthesis and evaluation of lantadene congeners.
    Suthar SK; Boon HL; Sharma M
    Eur J Med Chem; 2014 Mar; 74():135-44. PubMed ID: 24457265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel dual inhibitors of nuclear factor-kappa B (NF-κB) and cyclooxygenase- 2 (COX-2): synthesis, in vitro anticancer activity and stability studies of lantadene-non steroidal anti-inflammatory drug (NSAID) conjugates.
    Suthar SK; Sharma N; Lee HB; Nongalleima K; Sharma M
    Curr Top Med Chem; 2014; 14(8):991-1004. PubMed ID: 24660685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro anticancer studies of novel C-2 arylidene congeners of lantadenes.
    Tailor NK; Boon HL; Sharma M
    Eur J Med Chem; 2013 Jun; 64():285-91. PubMed ID: 23644211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, selective cancer cytotoxicity and mechanistic studies of novel analogs of lantadenes.
    Tailor NK; Jaiswal V; Lan SS; Lee HB; Sharma M
    Anticancer Agents Med Chem; 2013 Jul; 13(6):957-66. PubMed ID: 23293887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
    Hao J; Liu J; Wen X; Sun H
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-kappaB.
    Lin YC; Shun CT; Wu MS; Chen CC
    Clin Cancer Res; 2006 Dec; 12(23):7165-73. PubMed ID: 17145842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cytotoxicity evaluation of biaryl-based chalcones and their potential in TNFα-induced nuclear factor-κB activation inhibition.
    Zuo Y; Yu Y; Wang S; Shao W; Zhou B; Lin L; Luo Z; Huang R; Du J; Bu X
    Eur J Med Chem; 2012 Apr; 50():393-404. PubMed ID: 22386368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro.
    Milligan SA; Nopajaroonsri C
    Anticancer Res; 2001; 21(1A):39-44. PubMed ID: 11299767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of antitumor ursolic acid long-chain diamine derivatives as potent inhibitors of NF-κB.
    Jiang W; Huang RZ; Zhang J; Guo T; Zhang MT; Huang XC; Zhang B; Liao ZX; Sun J; Wang HS
    Bioorg Chem; 2018 Sep; 79():265-276. PubMed ID: 29778798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation.
    Lee KY; Park JS; Jee YK; Rosen GD
    Exp Mol Med; 2002 Dec; 34(6):462-8. PubMed ID: 12526088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
    Imre G; Gekeler V; Leja A; Beckers T; Boehm M
    Cancer Res; 2006 May; 66(10):5409-18. PubMed ID: 16707469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide and tumor necrosis factor-alpha production by oleanolic acid via nuclear factor-kappaB activation in macrophages.
    Choi CY; You HJ; Jeong HG
    Biochem Biophys Res Commun; 2001 Oct; 288(1):49-55. PubMed ID: 11594750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oleanolic acid analogs as NO, TNF-α and IL-1β inhibitors: synthesis, biological evaluation and docking studies.
    Bhandari P; Patel NK; Gangwal RP; Sangamwar AT; Bhutani KK
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4114-9. PubMed ID: 25113933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment.
    Schön M; Wienrich BG; Kneitz S; Sennefelder H; Amschler K; Vöhringer V; Weber O; Stiewe T; Ziegelbauer K; Schön MP
    J Natl Cancer Inst; 2008 Jun; 100(12):862-75. PubMed ID: 18544741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via alphavbeta3 integrin/FAK/ERK and NF-kappaB signaling pathway in human lung adenocarcinoma A549 cells.
    Shih YW; Chien ST; Chen PS; Lee JH; Wu SH; Yin LT
    Cell Biochem Biophys; 2010 Sep; 58(1):31-44. PubMed ID: 20652762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK; Wan CK; Shen XL; Yang M; Fong WF
    Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of lantadene A congener with hydroxyl functionality in ring A as an antitumour agent.
    Sharma M; Rakhi A; Dalal N; Sharma N
    Nat Prod Res; 2011 Feb; 25(4):387-96. PubMed ID: 20623424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, cytotoxicity, and antitumor activity of lantadene-A congeners.
    Sharma M; Sharma PD; Bansal MP; Singh J
    Chem Biodivers; 2007 May; 4(5):932-9. PubMed ID: 17511006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of novel
    Xie X; Tu J; You H; Hu B
    Drug Des Devel Ther; 2017; 11():1439-1451. PubMed ID: 28553074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.